Creon DR 36,000 unit capsule UU 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FY184
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,833
Award facts
- Contract value 100% obligated
- $23,832.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $23,832.72 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy).
Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of April 20, 2026. No set-aside was used. The source does not identify the parent vehicle by name.
Quick answers
Who was awarded contract SPE2DR26FY184?
SPE2DR26FY184 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 17, 2026.
How much is contract SPE2DR26FY184 worth?
The government has obligated $23,833 on SPE2DR26FY184.
Is contract SPE2DR26FY184 an order under another contract?
Yes. SPE2DR26FY184 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FY184 competed?
The extent of competition for SPE2DR26FY184 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award